StemCyte, Inc.
Quick facts
Phase 3 pipeline
- REGENECYTE · Regenerative Medicine
REGENECYTE is a cell therapy that uses expanded autologous bone marrow-derived stem cells to promote tissue regeneration and repair.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: